Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Rank in Stocks #33751
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Share Price
$0.4523
Last synced: 2023-03-03
Market Cap
$6.97M
Change (1 day)
-19.23%
Change (1 year)
0.00%
Country
US
Trade Lucira Health, Inc. (LHDX)

Category

Stock split history for Lucira Health, Inc. (LHDX)
Lucira Health, Inc. stock (symbol: LHDX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One LHDX share bought prior to Aug 17, 2026 would equal to 0 LHDX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US